SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-182914
Filing Date
2022-06-27
Accepted
2022-06-27 16:36:29
Documents
5
Effectiveness Date
2022-06-27

Document Format Files

Seq Description Document Type Size
1 S-8 d369503ds8.htm S-8 54274
2 EX-5.1 d369503dex51.htm EX-5.1 6823
3 EX-23.1 d369503dex231.htm EX-23.1 1538
4 EX-FILING FEES d369503dexfilingfees.htm EX-FILING FEES 14520
5 GRAPHIC g369503snap2.jpg GRAPHIC 10191
  Complete submission text file 0001193125-22-182914.txt   92560
Mailing Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007
Business Address 2533 S COAST HWY 101 SUITE 210 CARDIFF CA 92007 858-400-8470
Viracta Therapeutics, Inc. (Filer) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-265858 | Film No.: 221045092
SIC: 2834 Pharmaceutical Preparations